Medpace Holdings, Inc. (MEDP) Stock
Fundamentals
Latest news
About Medpace Holdings, Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. August James Troendle M.D. | CEO, President & Chairman | 1956 |
| Mr. Kevin M. Brady | CFO & Treasurer | 1975 |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary | 1969 |
| Mr. Brad W. Hansman | Executive Vice President of Operations | 1983 |
| Ms. Lauren Morris | Associate Director of Investors Relations | — |
| Mr. Todd Meyers | Vice President of Business Development & Marketing | — |
| Mr. Weimin Gai MS | Senior Vice President of Biometrics | — |
| Mr. John T. Wynne MBA | Chief Business Officer | — |
| Ms. Reinilde Heyrman M.D. | Chief Medical Officer of Medical Department | 1961 |
| Ms. Gina Leisring M.P.H. | Senior Vice President of Clinical Monitoring | — |



